$185 Million is the total value of Kopp Family Office, LLC's 14 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | Horizon Therapeutics Public Limited Company | $57,322,000 | -3.1% | 544,835 | -0.7% | 30.98% | +19.8% |
| IEFA | Buy | ISHARES TRcore msci eafe | $26,473,000 | -2.5% | 380,847 | +4.7% | 14.31% | +20.5% |
| JAMF | Buy | JAMF HOLDING CORP | $21,388,000 | -5.9% | 614,410 | +2.8% | 11.56% | +16.3% |
| VCEL | Buy | Vericel Corporation | $21,133,000 | -1.0% | 552,925 | +1.8% | 11.42% | +22.3% |
| NEO | Buy | NeoGenomics Inc. | $19,613,000 | -64.3% | 1,614,263 | +0.1% | 10.60% | -55.9% |
| FIVN | Buy | Five9, Inc. | $18,361,000 | -12.1% | 166,310 | +9.4% | 9.92% | +8.7% |
| IEMG | Buy | ISHARES TRcore msci emkt | $16,933,000 | -5.3% | 304,825 | +2.0% | 9.15% | +17.0% |
| MITK | Buy | MITEK SYS INC | $3,479,000 | -17.2% | 237,128 | +0.2% | 1.88% | +2.3% |
| ISTB | ISHARES TRcore 1 5 yr usd | $108,000 | -3.6% | 2,228 | 0.0% | 0.06% | +18.4% | |
| IVV | ISHARES TRcore s&p500 etf | $106,000 | -5.4% | 234 | 0.0% | 0.06% | +16.3% | |
| IAGG | ISHARES TRcore intl aggr | $45,000 | -4.3% | 862 | 0.0% | 0.02% | +14.3% | |
| IMTB | ISHARES TRcr 5 10 yr etf | $39,000 | -7.1% | 834 | 0.0% | 0.02% | +16.7% | |
| IJH | ISHARES TRcore s&p mcp etf | $33,000 | -5.7% | 122 | 0.0% | 0.02% | +20.0% | |
| IJR | ISHARES TRcore s&p scp etf | $18,000 | -5.3% | 169 | 0.0% | 0.01% | +25.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 16 | Q3 2023 | 90.1% |
| Vericel Corporation | 16 | Q3 2023 | 14.5% |
| Five9, Inc. | 16 | Q3 2023 | 11.2% |
| ISHARES TR | 13 | Q3 2023 | 16.7% |
| ISHARES TR | 13 | Q3 2023 | 10.6% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
View Kopp Family Office, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| RTI Surgical Holdings, Inc. | July 07, 2020 | ? | ? |
| NEOGENOMICS INC | January 07, 2020 | 4,844,625 | 4.6% |
| OCLARO, INC. | January 04, 2019 | ? | ? |
| SUPERCONDUCTOR TECHNOLOGIES INC | October 05, 2018 | ? | ? |
View Kopp Family Office, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-16 |
View Kopp Family Office, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.